Pharmalot Ed Silverman Pharmalittle: Advances in treating the sickest Covid patients have stalled; Moderna aids WHO effort to develop mRNA coronavirus shots
Pharmalot Ed Silverman Pharmalittle: CRISPR-based drug shows promise in preliminary study; FDA user fee program prompts fresh worries over conflicts
Biotech Megan Molteni Intellia says CRISPR treatment safely corrects DNA of six patients with rare disease
Pharmalot Ed Silverman Brazil dismisses antitrust complaint against Gilead over pricing for a hepatitis C drug
Pharmalot Ed Silverman Pharmalittle: Swiss authorities probe Novartis over patent used to block rivals; Medicare underserves older Americans with opioid use disorder
Pharmalot Ed Silverman Swiss authorities raid Novartis offices seeking info on patents used to block rivals
Pharmalot Ed Silverman Pharmalittle: Pharma pursues the ‘dream’ of online prescribing; EC chief under fire over Pfizer vaccine contract
Health Tech Katie Palmer ‘This is pharma’s dream’: How drugmakers are turning telehealth into a marketing gold mine
Pharmalot Ed Silverman Pharmalittle: Biden picks biotech exec to lead new biomedical research agency; FDA to hold meeting for OTC birth control pill
Biotech Adam Feuerstein Akero treatment for NASH reduces liver scarring, achieves goals of mid-stage study
Biotech Adam Feuerstein Data likely support approval of Amgen’s KRAS-targeted drug, but still come with disappointments
Biotech Ryan Cross — The Boston Globe Pretzel Therapeutics, eyeing diseases caused by broken mitochondria, launches with $72.5 million
Pharmalot Ed Silverman Pharmalittle: FDA approves new type of psoriasis drug; U.S. starts late-stage trial to test an antiviral against monkeypox
Business Bob Herman Experts urge Medicare to overhaul secretive panel that helps determine doctors’ pay
Biotech Jason Mast Cancer treatment devised in the 1980s has proven effective (again). Will it finally get approval?
Pharmalot Ed Silverman USDA starts cracking down on companies that ship animals without timely inspections
Pharmalot Ed Silverman J&J wins a partial appeal against the U.K.’s cost-effectiveness watchdog over ‘unfair’ review
Pharmalot Ed Silverman Pharmalittle: FDA approves a new wrinkle drug; running remote clinical trials can save pharma money
Pharmalot Ed Silverman What disclosure? Clinical trials run in Canada fail to take basic steps toward transparency
